- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pemetrexed Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pemetrexed Drugmarket, defines the market attractiveness level of Pemetrexed Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pemetrexed Drug industry, describes the types of Pemetrexed Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pemetrexed Drug market and the development prospects and opportunities of Pemetrexed Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pemetrexed Drug market in Chapter 13.
By Player:
Pfizer
Teva
Eli Lilly and Company
Qilu Pharmaceutical
Biocon
APOTEX
Eagle Pharmaceuticals
By Type:
100 mg lyophilized Powder/Vial
500 mg lyophilized Powder/Vial
By End-User:
Pleural Mesothelioma
Non-small Cell Lung Cancer
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pemetrexed Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pemetrexed Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pemetrexed Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pemetrexed Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pemetrexed Drug Market Analysis and Outlook to 2022
-
7.1 Global Pemetrexed Drug Consumption (2017-2022)
-
7.2 United States Pemetrexed Drug Consumption (2017-2022)
-
7.3 Europe Pemetrexed Drug Consumption (2017-2022)
-
7.4 China Pemetrexed Drug Consumption (2017-2022)
-
7.5 Japan Pemetrexed Drug Consumption (2017-2022)
-
7.6 India Pemetrexed Drug Consumption (2017-2022)
-
7.7 South Korea Pemetrexed Drug Consumption (2017-2022)
8 Region and Country-wise Pemetrexed Drug Market Analysis and Outlook to 2028
-
8.1 Global Pemetrexed Drug Consumption Forecast (2022-2028)
-
8.2 United States Pemetrexed Drug Consumption Forecast (2022-2028)
-
8.3 Europe Pemetrexed Drug Consumption Forecast (2022-2028)
-
8.4 China Pemetrexed Drug Consumption Forecast (2022-2028)
-
8.5 Japan Pemetrexed Drug Consumption Forecast (2022-2028)
-
8.6 India Pemetrexed Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Pemetrexed Drug Consumption Forecast (2022-2028)
9 Global Pemetrexed Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Pemetrexed Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 100 mg lyophilized Powder/Vial Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 500 mg lyophilized Powder/Vial Consumption and Growth Rate (2017-2022)
-
9.2 Global Pemetrexed Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pleural Mesothelioma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Non-small Cell Lung Cancer Consumption and Growth Rate (2017-2022)
10 Global Pemetrexed Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Pemetrexed Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 100 mg lyophilized Powder/Vial Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 500 mg lyophilized Powder/Vial Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pemetrexed Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pleural Mesothelioma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Non-small Cell Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
11 Global Pemetrexed Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pemetrexed Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pemetrexed Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pemetrexed Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pemetrexed Drug Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Pemetrexed Drug Product and Service
-
14.2 Teva
-
14.2.1 Teva Company Details
-
14.2.2 Teva Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Teva Pemetrexed Drug Product and Service
-
14.3 Eli Lilly and Company
-
14.3.1 Eli Lilly and Company Company Details
-
14.3.2 Eli Lilly and Company Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly and Company Pemetrexed Drug Product and Service
-
14.4 Qilu Pharmaceutical
-
14.4.1 Qilu Pharmaceutical Company Details
-
14.4.2 Qilu Pharmaceutical Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Qilu Pharmaceutical Pemetrexed Drug Product and Service
-
14.5 Biocon
-
14.5.1 Biocon Company Details
-
14.5.2 Biocon Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biocon Pemetrexed Drug Product and Service
-
14.6 APOTEX
-
14.6.1 APOTEX Company Details
-
14.6.2 APOTEX Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 APOTEX Pemetrexed Drug Product and Service
-
14.7 Eagle Pharmaceuticals
-
14.7.1 Eagle Pharmaceuticals Company Details
-
14.7.2 Eagle Pharmaceuticals Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eagle Pharmaceuticals Pemetrexed Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pemetrexed Drug
-
Figure Pemetrexed Drug Picture
-
Table Global Pemetrexed Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pemetrexed Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pemetrexed Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pemetrexed Drug Consumption by Country (2017-2022)
-
Figure United States Pemetrexed Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Pemetrexed Drug Consumption and Growth Rate (2017-2022)
-
Figure China Pemetrexed Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Pemetrexed Drug Consumption and Growth Rate (2017-2022)
-
Figure India Pemetrexed Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pemetrexed Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Pemetrexed Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Pemetrexed Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pemetrexed Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pemetrexed Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pemetrexed Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pemetrexed Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pemetrexed Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100 mg lyophilized Powder/Vial Consumption and Growth Rate (2017-2022)
-
Figure Global 500 mg lyophilized Powder/Vial Consumption and Growth Rate (2017-2022)
-
Figure Global Pleural Mesothelioma Consumption and Growth Rate (2017-2022)
-
Figure Global Non-small Cell Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global 100 mg lyophilized Powder/Vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 500 mg lyophilized Powder/Vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pleural Mesothelioma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-small Cell Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pemetrexed Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pemetrexed Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Pemetrexed Drug Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pemetrexed Drug Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Pemetrexed Drug Product and Service
-
Table Qilu Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Qilu Pharmaceutical Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qilu Pharmaceutical Pemetrexed Drug Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Pemetrexed Drug Product and Service
-
Table APOTEX (Foundation Year, Company Profile and etc.)
-
Table APOTEX Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table APOTEX Pemetrexed Drug Product and Service
-
Table Eagle Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Eagle Pharmaceuticals Pemetrexed Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eagle Pharmaceuticals Pemetrexed Drug Product and Service
-